Literature DB >> 10430053

T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis.

K Kil1, Y C Zang, D Yang, J Markowski, G S Fuoco, G C Vendetti, V M Rivera, J Z Zhang.   

Abstract

Autoimmune inflammation secondary to myelin destruction may play an inhibitory role in restoration of nerve functions in spinal cord injury (SCI). In this study, we demonstrated that T cells recognizing myelin basic protein (MBP) occurred at a high precursor frequency in patients with SCI, which was compatible to that in patients with multiple sclerosis (MS), a disease of presumed autoimmune pathology. The findings suggest of hyperactivity of MBP-reactive T cells in patients with SCI. MBP-reactive T cell lines derived from patients with SCI exhibited a preferential recognition pattern toward the 81-99 and the 151-169 regions of MBP. There were functional differences in the epitope recognition and cytokine profile between two panels of MBP-reactive T cell lines derived from patients with SCI and patients with MS. The study provides new evidence important for further investigation of the role of the inflammatory component in SCI.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430053     DOI: 10.1016/s0165-5728(99)00057-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  31 in total

Review 1.  Failed central nervous system regeneration: a downside of immune privilege?

Authors:  Ingo Bechmann
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Tolerogenic effect of fiber tract injury: reduced EAE severity following entorhinal cortex lesion.

Authors:  Leman Mutlu; Christine Brandt; Erik Kwidzinski; Birgit Sawitzki; Ulrike Gimsa; Jacqueline Mahlo; Orhan Aktas; Robert Nitsch; Marloes van Zwam; Jon D Laman; Ingo Bechmann
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

Review 3.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

Review 4.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

5.  Neurotoxic or Neuroprotective? Current Controversies in SCI-Induced Autoimmunity.

Authors:  Jonah W Saltzman; Ricardo Battaglino; Helen Stott; Leslie R Morse
Journal:  Curr Phys Med Rehabil Rep       Date:  2013-09

6.  Autoreactivity against myelin basic protein in patients with chronic paraplegia.

Authors:  D Zajarías-Fainsod; J Carrillo-Ruiz; H Mestre; I Grijalva; I Madrazo; A Ibarra
Journal:  Eur Spine J       Date:  2011-11-08       Impact factor: 3.134

Review 7.  Multiple sclerosis in childhood and adolescence: clinical features and management.

Authors:  O Pinhas-Hamiel; I Sarova-Pinhas; A Achiron
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 8.  The potential role of B cell-targeted therapies in multiple sclerosis.

Authors:  Aaron Boster; Daniel P Ankeny; Michael K Racke
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

9.  B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice.

Authors:  Daniel P Ankeny; Zhen Guan; Phillip G Popovich
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 10.  The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury.

Authors:  Jan M Schwab; Yi Zhang; Marcel A Kopp; Benedikt Brommer; Phillip G Popovich
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.